Background: The nomogram derived from the pivotal phase III NAPOLI-1 study demonstrated a significant ability to predict median overall survival (OS) in gemcitabine-refractory metastatic pancreatic ductal adenocarcinoma (PDAC) treated with liposomal irinotecan plus fluorouracil and leucovorin (nal-IRI+5-FU/LV). However, the NAPOLI-1 nomogram has not been validated in a real-world setting and therefore the applicability of the NAPOLI-1 nomogram in daily practice remains unknown. This study aims to evaluate the NAPOLI-1 nomogram in a multicenter real-world cohort. Methods: The NAPOLI-1 nomogram was applied to a previously established cohort of metastatic PDAC patients treated with nal-IRI+5-FU/LV in nine participating centers in Taiwan. Patie...
Introduction: Lymph node ratio (LNR) is an important prognostic factor of survival in patients with ...
BACKGROUND: We developed a nomogram for predicting survival of patients with locally advanced pancre...
AbstractIntroduction. Survival following resection for pancreatic ductal adenocarcinoma (PDAC) remai...
[[abstract]]BACKGROUND: The nomogram derived from the pivotal phase III NAPOLI-1 study demonstrated ...
[[abstract]]NAPOLI-1 (NCT01494506) was a phase III study of liposomal irinotecan (nal-IRI) plus 5-fl...
[[abstract]]Background: Results from NAPOLI-1 (NCT01494506), a phase 3 study in pts with mPDAC previ...
[[abstract]]Background: NAPOLI-1 (NCT01494506) was a global phase 3 study in pts with mPDAC previous...
Càncer de pàncrees metastàtic; Nomograma; PronòsticCáncer de páncreas metastásico; Nomograma; Pronós...
Background: FOLFIRINOX (leucovorin, 5-fluorouracil, irinotecan, and oxaliplatin) is an option for fi...
Abstract Background Nomograms are rarely employed to estimate the survival of patients with advanced...
Lymph node ratio (LNR) is an important prognostic factor of survival in patients with pancreatic duc...
Introduction: Lymph node ratio (LNR) is an important prognostic factor of survival in patients with ...
BACKGROUND: We developed a nomogram for predicting survival of patients with locally advanced pancre...
AbstractIntroduction. Survival following resection for pancreatic ductal adenocarcinoma (PDAC) remai...
[[abstract]]BACKGROUND: The nomogram derived from the pivotal phase III NAPOLI-1 study demonstrated ...
[[abstract]]NAPOLI-1 (NCT01494506) was a phase III study of liposomal irinotecan (nal-IRI) plus 5-fl...
[[abstract]]Background: Results from NAPOLI-1 (NCT01494506), a phase 3 study in pts with mPDAC previ...
[[abstract]]Background: NAPOLI-1 (NCT01494506) was a global phase 3 study in pts with mPDAC previous...
Càncer de pàncrees metastàtic; Nomograma; PronòsticCáncer de páncreas metastásico; Nomograma; Pronós...
Background: FOLFIRINOX (leucovorin, 5-fluorouracil, irinotecan, and oxaliplatin) is an option for fi...
Abstract Background Nomograms are rarely employed to estimate the survival of patients with advanced...
Lymph node ratio (LNR) is an important prognostic factor of survival in patients with pancreatic duc...
Introduction: Lymph node ratio (LNR) is an important prognostic factor of survival in patients with ...
BACKGROUND: We developed a nomogram for predicting survival of patients with locally advanced pancre...
AbstractIntroduction. Survival following resection for pancreatic ductal adenocarcinoma (PDAC) remai...